Ovarian Cancer News and Research

RSS
Commonly known as the "silent killer," ovarian cancer leads to approximately 15,000 deaths each year in the United States, according to the American Cancer Society. Approximately 20,000 new cases are diagnosed each year, with the majority in patients diagnosed with late stage disease where the cancer has spread beyond the ovary. The prognosis is poor in these patients, leading to the high mortality from this disease. A diagnostic test is needed that can provide adequate predictive value to stratify patients with a pelvic mass into high risk of invasive ovarian cancer versus those with low risk, as well as a screening test for the diagnosis of early-stage ovarian cancer, which is essential for improving overall survival in patients. Ovarian cancer has up to a 90% cure rate following surgery and/or chemotherapy if detected in stage 1.
Researchers investigate why some cancers affect only young women

Researchers investigate why some cancers affect only young women

New blood test could spare cancer patients from unnecessary chemotherapy

New blood test could spare cancer patients from unnecessary chemotherapy

First-of-its-kind study to test a personalized vaccine in cancer patient

First-of-its-kind study to test a personalized vaccine in cancer patient

Greater family size reduces cancer risk

Greater family size reduces cancer risk

Cancer cells hijack communication between fallopian tube and ovary to drive tumor growth

Cancer cells hijack communication between fallopian tube and ovary to drive tumor growth

Beyond BRCA: Epigenetic Silencing in Breast Cancer

Beyond BRCA: Epigenetic Silencing in Breast Cancer

Low-dose aspirin use associated with reduced ovarian cancer risk

Low-dose aspirin use associated with reduced ovarian cancer risk

Promising vaccine may provide new treatment option for patients with HER2-positive cancers

Promising vaccine may provide new treatment option for patients with HER2-positive cancers

Australian scientists resolve a key question in ovarian cancer care

Australian scientists resolve a key question in ovarian cancer care

Loyola announces plans to produce CAR-T cells for treating cancer

Loyola announces plans to produce CAR-T cells for treating cancer

Ovarian cancer risk reduced among women taking modern combined oral contraceptive pills

Ovarian cancer risk reduced among women taking modern combined oral contraceptive pills

Addition of CTLA4 targeted therapy to PD-1 targeted therapy may benefit patients with ovarian cancer

Addition of CTLA4 targeted therapy to PD-1 targeted therapy may benefit patients with ovarian cancer

Researchers reveal how rapidly spreading ovarian cancer cells take the next steps

Researchers reveal how rapidly spreading ovarian cancer cells take the next steps

Verastem doses first patient in Phase I/II clinical trial of duvelisib in combination with venetoclax

Verastem doses first patient in Phase I/II clinical trial of duvelisib in combination with venetoclax

Researchers predict how splicing errors impact disease risk

Researchers predict how splicing errors impact disease risk

Protein modifications that indicate disease

Protein modifications that indicate disease

Tips to know your ovarian cancer risk and symptoms

Tips to know your ovarian cancer risk and symptoms

Adherence to ovarian cancer screening guidelines may be lower among physicians with nonprofessional cancer experience

Adherence to ovarian cancer screening guidelines may be lower among physicians with nonprofessional cancer experience

Breastfeeding may reduce risk for stroke in post-menopausal women

Breastfeeding may reduce risk for stroke in post-menopausal women

UCLA professor shares five facts about ovarian cancer

UCLA professor shares five facts about ovarian cancer